A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?
about
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds EnBayesian inference for two-part mixed-effects model using skew distributions, with application to longitudinal semicontinuous alcohol data.Bias in 2-part mixed models for longitudinal semicontinuous data.Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.A likelihood-based two-part marginal model for longitudinal semicontinuous data.Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal studyThe burden of psoriatic arthritis: a literature review from a global health systems perspective.Methods for observed-cluster inference when cluster size is informative: a review and clarifications.Two-part models with stochastic processes for modelling longitudinal semicontinuous data: Computationally efficient inference and modelling the overall marginal mean.The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting.Patient involvement in outcome measures for psoriatic arthritis.Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies?Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.Patient-Reported Outcomes in Psoriatic Arthritis.Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry.Two-Part and Related Regression Models for Longitudinal Data.Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis.Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.Distinguishing between-person and within-person relationships in longitudinal health research: arthritis and quality of life.Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?Update on the treatment of psoriasis and psoriatic arthritis - role of apremilast.
P2860
Q26862017-F4BC1910-E68D-4685-94CC-D16856AE598AQ30975433-DC73A7F6-ECCB-4051-B8E0-5D60A80FFD58Q33399008-EE1507DC-6D13-40F4-A7FE-903686263F1FQ33858767-CDF5F4E4-CBF3-4E90-BDC8-BD06934D1272Q34004468-F4128241-32AE-4A6D-A222-55B221D495B5Q34099501-8A17831C-F067-4FC7-AE3B-6D4F992994CBQ34174214-5439EC41-835C-4E29-8E78-3D994BD99E9CQ34432846-5444A11A-E36E-494D-AB05-0AF368DAEE58Q35035067-B7AC31E1-7532-4D8A-9CF5-694BF972CE62Q36378761-20CB262B-ECD0-4275-A92D-A262393C871DQ37172521-01C75E7C-B3CE-4A47-B108-D55D55147AD1Q37862369-C28D3220-0D9D-4CAF-B0E5-95FC20F46613Q38195568-95AED00F-C3B3-441D-A13E-E84FB4EBB742Q38202212-7ED9D50D-2C45-4DAA-A636-FBF8C22C45B0Q38690324-548760FA-77AD-49E1-A923-BADA0E8DBEF3Q38822369-4B2CA83B-0D1F-4B44-A5ED-40560412B0ABQ38918484-9980E560-96D4-43E2-819B-514CDEA8FB13Q39993595-B8C3E3B3-CDD1-4C64-95F2-61CDB7F4AE4FQ40074154-2E377602-0A51-4FDB-9982-49E4BF1E2730Q41502118-7E05C23A-A9C8-47EA-B242-C6515F5CBC19Q43411680-357CDA2B-8E7D-4F40-A3BF-5D22C1ECD6E9Q44577959-7311E663-0CE7-4374-AAB6-97C85BCF0862Q48493352-E4F54A70-95B8-4206-97FE-31419F51C6FAQ48552102-0448CF5D-73C7-494B-AD29-AA7F1630284CQ55177045-7E592643-BB55-4327-8D0B-23F5F22CA544
P2860
A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A longitudinal study of the ef ...... s the effect change over time?
@en
A longitudinal study of the ef ...... s the effect change over time?
@nl
type
label
A longitudinal study of the ef ...... s the effect change over time?
@en
A longitudinal study of the ef ...... s the effect change over time?
@nl
prefLabel
A longitudinal study of the ef ...... s the effect change over time?
@en
A longitudinal study of the ef ...... s the effect change over time?
@nl
P50
P356
P1476
A longitudinal study of the ef ...... s the effect change over time?
@en
P2093
Catherine T Schentag
Janice A Husted
P304
P356
10.1002/ART.22443
P577
2007-03-01T00:00:00Z